NCT02637141 - A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 13, 2016

Primary Completion Date

February 15, 2017

Study Completion Date

March 14, 2017

Conditions

Celiac Disease

Interventions

BIOLOGICAL

AMG 714

AMG 714 administered by subcutaneous injection

BIOLOGICAL

Placebo

Matching placebo to AMG 714 administered by subcutaneous injection

OTHER

Placebo Gluten Challenge

Gluten-free cookies (Finnish rusks)

OTHER

Gluten Challenge

Gluten-containing cookies (Finnish rusks), 1-2 g gluten per serving

Trial Locations (3)

ODL, Oulu

Tampere University Hospital, Tampere

CRST, Turku